The 2 Minute Medicine® Podcast

2 Minute Medicine®
  • 5.0 (4)
  • Medicine
  • Biweekly

The 2 Minute Medicine® Podcast: the week's most talked-about medical studies and trial results in about seven minutes, every Monday morning, curated and written by practicing physicians. Hosts Mike and Michelle break down what was found, how strong the evidence is, and what it means for patients and practice. For the latest physician-written medical news, visit 2minutemedicine.com or download the free 2 Minute Medicine app for iPhone and Android: daily study summaries, visual abstracts, EvidencePulse and more. Follow us @2minmed.

  1. 19h ago

    AI Health Brief – Explainable Imaging Foundation Model, Grading Chatbots on Teen Mental Health, Chatbot for Social Needs, and More

    This week on the AI Health Brief, a Nature Medicine study introduces EVLF-FM, an explainable vision language model trained and tested on more than 1.3 million samples across 10 imaging modalities. RAND-led researchers grade ChatGPT, Claude and Gemini on conversations with simulated teens, and a PLOS Digital Health study tests Daphne, a chatbot that screens caregivers for social needs. In the news, the parents of Bowen Wan, a 31-year-old Seattle woman with epilepsy, file a wrongful death lawsuit alleging ChatGPT coached her to taper off her seizure medication; OpenAI calls her death heartbreaking. And in market movers, Teladoc jumps about 34 percent, Butterfly Network slides about 17 percent in the same week it raised its outlook, and GE HealthCare climbs about 12 percent as it unveils new imaging and ultrasound tools. The studies: • Explainable Imaging Foundation Model: https://doi.org/10.1038/s41591-026-04655-5 • Grading Chatbots on Teen Mental Health: https://doi.org/10.1038/s44220-026-00753-y • Chatbot for Social Needs: https://doi.org/10.1371/journal.pdig.0001789 In the news: • ChatGPT Epilepsy Death Lawsuit: https://ground.news/article/parents-sue-openai-alleging-gpt-4o-coached-their-daughter-off-seizure-medication • ChatGPT Epilepsy Death Lawsuit: https://socialmediavictims.org/press-releases/smvlc-schenk-file-openai-chatgpt-epilepsy-wrongful-death-lawsuit/ • ChatGPT Epilepsy Death Lawsuit: https://www.kiro7.com/news/local/seattle-womans-family-sues-openai-claims-chatgpt-coached-her-off-medication-before-death/YV3O46Q65NC5LBMKEKFVLZRY5Y/ Market movers: • Teladoc's Big Week (TDOC, up 33.8% for the week) • Butterfly Network Slides (BFLY, down 16.8% for the week) • GE HealthCare Climbs (GEHC, up 11.9% for the week) Read physician-written summaries of the latest studies at https://www.2minutemedicine.com This episode is for information only and is not investment advice.

    AI Health Brief – Explainable Imaging Foundation Model, Grading Chatbots on Teen Mental Health, Chatbot for Social Needs, and More

  2. 2d ago

    The 2 Minute Medicine® Podcast – Silver Diamine Fluoride for Cavities, Atezolizumab for dMMR Colon Cancer, Retatrutide Versus Ozempic, Geron Halts Imetelstat Trial, and More

    In this episode, we review the week's most-covered medical studies and trial results. Our study of the week comes from JAMA Pediatrics and is entitled “Efficacy of Silver Diamine Fluoride on Young Children With Severe Early Childhood Caries”. We then discuss the ATOMIC trial of atezolizumab plus mFOLFOX6 chemotherapy for stage III mismatch repair-deficient colon cancer, and Eli Lilly’s topline results comparing retatrutide with Ozempic in adults with type 2 diabetes. Next, we cover Geron’s decision to discontinue its phase 3 trial of imetelstat in myelofibrosis, the SAFFRON trial of osimertinib plus savolitinib in EGFR-mutated, MET-altered non-small-cell lung cancer, and Pennsylvania’s statewide measles outbreak. Finally, we look at topline results for trastuzumab pamirtecan in hormone receptor positive, HER2-low metastatic breast cancer. In this episode: • Silver Diamine Fluoride for Cavities: https://doi.org/10.1001/jamapediatrics.2026.2567 • Atezolizumab for dMMR Colon Cancer: https://doi.org/10.1056/nejmoa2507874 • Retatrutide Versus Ozempic: https://clinicaltrials.gov/study/NCT06260722 2 Minute Medicine summary: https://www.2minutemedicine.com/in-topline-phase-3-results-retatrutide-lowered-a1c-more-and-reduced-weight-more-than-semaglutide-2-mg-at-80-weeks/ • Geron Halts Imetelstat Trial: https://ir.geron.com/news-events/news-releases • Osimertinib Plus Savolitinib: https://doi.org/10.1056/nejmoa2611335 • Pennsylvania Measles Outbreak: https://doi.org/10.1001/jama.2026.22533 2 Minute Medicine summary: https://www.2minutemedicine.com/pennsylvania-reports-1260-measles-cases-across-43-counties-in-2026/ • Trastuzumab Pamirtecan Breast Cancer: https://www.nasdaq.com/press-release/biontech-and-dualitybio-announce-topline-results-dynasty-breast02-global-phase-3-1 Read physician-written summaries of the latest studies at https://www.2minutemedicine.com

  3. Sep 11

    The 2 Minute Medicine® Podcast – Opioid Treatment, Menopause Cocktail, Maxxing Trends, Ebola, and Coffee & Body Composition

    In this episode, we look at how social media continues to shape the way patients think about their health, for better and for worse. This week’s article comes from JAMA Network Open and is entitled “Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors”. After discussing this article, we begin with a conversation about the online "menopause cocktail" trend combining Allegra and Pepcid, then look at how "-maxxing" culture has spread from appearance forums into sleep optimization and adolescent body image. We then turn to the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, now the largest Ebola outbreak ever recorded in the country. Finally, we discuss a Finnish cohort study linking habitual coffee consumption to leaner body composition independent of BMI.

  4. Jul 1

    The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”

    In this episode, we explore how artificial intelligence is continuing to move deeper into healthcare infrastructure and clinical practice. We begin with the Food and Drug Administration's review of an artificial intelligence tool designed to predict drug-induced liver injury during drug development. We then examine a new certification program launched by The Joint Commission focused on responsible artificial intelligence governance in healthcare organizations. Finally, we discuss how pediatric hospitals are beginning to deploy generative artificial intelligence tools to reduce administrative burden and support clinical workflows.

  5. Jun 24

    The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face"

    In this episode, we explore how social media, celebrity influence, and emerging science continue to shape healthcare conversations around the world. The article of the week comes from from Annals of Internal Medicine entitled “Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation.” In the second half, we take a deep dive into the growing whole-body MRI screening trend promoted by celebrities and the concerns radiologists are raising about incidental findings and unnecessary follow-up testing. We then examine a rare Andes hantavirus outbreak aboard an expedition cruise ship that prompted contact tracing efforts across 32 countries. Next, we discuss reports of emotional blunting among some patients taking GLP-1 receptor agonists alongside new genetic data that may explain why certain individuals do not respond to these medications. Finally, we break down the viral “cortisol face” trend and why endocrinologists are cautioning against unnecessary cortisol testing.

  6. May 7

    The 2 Minute Medicine® Podcast- Asundexian for Secondary Stroke Prevention, “Fibermaxxing,” Red Light Therapy, Mouth Taping Risks, and WHO Schizophrenia Care Initiative Summary

    In this episode, we explore how social media and celebrity influence are reshaping health behaviors at scale. The article of the week comes from the New England Journal of Medicine and is entitled “Asundexian for secondary stroke prevention.”We start with the viral “Fibermaxxing” trend and its growing focus on microbiome health and satiety. We then examine how Jennifer Aniston’s longevity campaign has pushed red light therapy into the mainstream wellness conversation. Next, we break down an urgent safety warning from the American Lung Association regarding the risks of the mouth taping sleep trend. We conclude with a major global initiative from the World Health Organization aimed at closing the longstanding mortality gap in schizophrenia through integrated care models.

  7. May 7

    The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary:

    In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss of efficacy. The episode then examines Eli Lilly’s investigational triple-agonist retatrutide, which is showing unprecedented weight loss and glycemic control in patients with type 2 diabetes. Finally, we discuss a recent FDA warning issued to Novo Nordisk regarding delayed adverse event reporting and what this means for clinicians as GLP-1 therapies continue to expand rapidly in clinical practice.

  8. Apr 23

    The 2 Minute Medicine® Podcast- Roche’s AI Factory, Amazon’s Health Assistant, Surgical Robotics Breakthroughs, and Chatbot Safety Concerns

    In this special deep-dive episode of the 2 Minute Medicine® Podcast, we explore the rapid transformation of artificial intelligence across the healthcare landscape, beginning with Roche’s launch of a large-scale AI factory designed to accelerate drug discovery and manufacturing. We review how NVIDIA-powered systems and “Lab-in-the-Loop” models are enabling real-time refinement of biological predictions and reshaping pharmaceutical research pipelines. The episode then examines Amazon’s expansion of its Health AI assistant, highlighting how conversational AI is changing patient engagement and clinical workflows. We also discuss emerging advances in surgical robotics, including NVIDIA’s Isaac GR00T N model, which may enhance procedural precision and standardize outcomes. Finally, we address growing ethical concerns surrounding AI-powered mental health chatbots, including risks related to bias, safety, and inadequate escalation in high-risk scenarios.

See All (79)

Ratings & Reviews

5
out of 5
4 Ratings

About

The 2 Minute Medicine® Podcast: the week's most talked-about medical studies and trial results in about seven minutes, every Monday morning, curated and written by practicing physicians. Hosts Mike and Michelle break down what was found, how strong the evidence is, and what it means for patients and practice. For the latest physician-written medical news, visit 2minutemedicine.com or download the free 2 Minute Medicine app for iPhone and Android: daily study summaries, visual abstracts, EvidencePulse and more. Follow us @2minmed.

Information